US Food and Drug Administration approves antiviral remdesivir to treat Covid-19

The US Food and Drug Administration (FDA) on Thursday approved Gilead Sciences, Inc’s antiviral drug remdesivir for treating patients hospitalised with Covid-19, making it the first and only drug approved for the disease in the United States.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *